Establishment Labs Reports Second Quarter 2025 Financial Results
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics ...
How might the 16.3% YoY revenue growth influence analyst sentiment and the stock’s price trajectory in the near term?
What is the company’s current debt level and liquidity position after the quarter’s results?
Is there any information on upcoming product launches, regulatory approvals, or pipeline developments that could impact future revenue?
16 days ago